mesalamine has been researched along with butyric acid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Anderson, FH | 1 |
| Caprilli, R; Cittadini, M; Torsoli, A; Vernia, P | 1 |
| Millard, S; Roediger, WE | 1 |
| Cosenza, V; D'Argenio, G; D'Armiento, FP; De Ritis, F; Delle Cave, M; Gatto, A; Mazzacca, G; Sorrentini, I | 1 |
| Davletshin, AI; Egorov, VV; Zubov, VP | 1 |
| Assisi, RF | 1 |
| Ben-Horin, S; de Haar, C; Ehehalt, R; Higgins, P; Karrasch, T; Latella, G; Rieder, F; Rogler, G; Sans, M; Scaldaferri, F; Schirbel, A; Velin, D; Wehkamp, J | 1 |
| Bai, X; Chen, L; Lin, Y; Liu, Z; Luo, Z; Yang, R; Zhang, Z; Zhong, Z; Zhou, M | 1 |
2 review(s) available for mesalamine and butyric acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Butyric Acid; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Defensins; Extracellular Matrix; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Leptin; Matrix Metalloproteinases; Mesalamine; Paneth Cells; Probiotics; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfasalazine; Tumor Necrosis Factor-alpha; Wound Healing | 2012 |
1 trial(s) available for mesalamine and butyric acid
| Article | Year |
|---|---|
Combined butyric acid/mesalazine treatment in ulcerative colitis with mild-moderate activity. Results of a multicentre pilot study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Butyric Acid; Colitis, Ulcerative; Drug Combinations; Female; Gastrointestinal Agents; Histamine Antagonists; Humans; Intestinal Mucosa; Inulin; Italy; Male; Mesalamine; Middle Aged; Pilot Projects; Tablets; Treatment Outcome | 2008 |
6 other study(ies) available for mesalamine and butyric acid
| Article | Year |
|---|---|
The rectal approach to treatment in distal ulcerative colitis.
Topics: Absorption; Administration, Rectal; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Butyric Acid; Colitis, Ulcerative; Colon; Fatty Acids, Volatile; Humans; Intestinal Mucosa; Mesalamine; Oxidation-Reduction; Steroids | 1995 |
Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate.
Topics: Administration, Topical; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Butyric Acid; Colitis, Ulcerative; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Enema; Female; Humans; Male; Mesalamine; Remission Induction; Time Factors | 1995 |
Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?
Topics: Aminosalicylic Acids; Animals; Butyrates; Butyric Acid; Carbon Dioxide; Cells, Cultured; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Fatty Acids; Female; Glucose; Humans; Ibuprofen; Mesalamine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 1995 |
Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity.
Topics: Aminosalicylic Acids; Animals; Butyrates; Butyric Acid; Colitis; Factor XIII; Male; Mesalamine; Rats; Rats, Wistar; Thromboxane B2; Transglutaminases | 1994 |
[Effect of surfactants on peroxidase activity. I. Effect of anionic surfactants].
Topics: Anions; Butyrates; Butyric Acid; Enzyme Inhibitors; Horseradish Peroxidase; Hydrogen-Ion Concentration; Kinetics; Luminescent Measurements; Mesalamine; Micelles; Oxidation-Reduction; Protein Conformation; Protein Denaturation; Structure-Activity Relationship; Surface-Active Agents | 1998 |
A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer.
Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclodextrins; Drug Delivery Systems; Folic Acid; Male; Mesalamine; Mice; Mice, Nude; Prodrugs | 2021 |